anmelden
OMX Nordic 40
2.624,48
PKT
+12,06
PKT
+0,46
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 21.08.20 | A.P. Moeller - Maersk A-S (B) Neutral | Goldman Sachs Group Inc. | |
| 21.08.20 | A.P. Moeller - Maersk A-S (B) Hold | Jefferies & Company Inc. | |
| 21.08.20 | A.P. Moeller - Maersk A-S (B) Neutral | JP Morgan Chase & Co. | |
| 20.08.20 | A.P. Moeller - Maersk A-S (B) buy | Deutsche Bank AG | |
| 20.08.20 | ABB (Asea Brown Boveri) Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 20.08.20 | A.P. Moeller - Maersk A-S (B) Outperform | Credit Suisse Group | |
| 19.08.20 | A.P. Moeller - Maersk A-S (B) Neutral | Goldman Sachs Group Inc. | |
| 18.08.20 | Novo Nordisk Neutral | UBS AG | |
| 18.08.20 | A.P. Moeller - Maersk A-S (B) buy | Kepler Cheuvreux | |
| 14.08.20 | Novo Nordisk Hold | Kepler Cheuvreux | |
| 11.08.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 11.08.20 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 11.08.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.08.20 | Novo Nordisk Outperform | Credit Suisse Group | |
| 07.08.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 07.08.20 | Novo Nordisk Outperform | Bernstein Research | |
| 07.08.20 | Novo Nordisk Outperform | Credit Suisse Group | |
| 06.08.20 | Novo Nordisk Neutral | UBS AG | |
| 06.08.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 06.08.20 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 06.08.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 06.08.20 | Volvo (B) buy | Jefferies & Company Inc. | |
| 03.08.20 | Nokia Neutral | Credit Suisse Group | |
| 03.08.20 | Nokia buy | Deutsche Bank AG | |
| 03.08.20 | Nokia Equal weight | Barclays Capital | |
| 03.08.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 01.08.20 | Nokia Neutral | Goldman Sachs Group Inc. | |
| 31.07.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 31.07.20 | Nokia buy | UBS AG | |
| 31.07.20 | Nokia Neutral | JP Morgan Chase & Co. | |
| 30.07.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 30.07.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 29.07.20 | AstraZeneca overweight | Barclays Capital | |
| 28.07.20 | Nokia Neutral | Credit Suisse Group | |
| 28.07.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 28.07.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 27.07.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 27.07.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 23.07.20 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 23.07.20 | ABB (Asea Brown Boveri) buy | UBS AG |